Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 1, 2006, Pages 34-43

  Wang, Chao Hung ^a   Verma, Subodh ^b   Hsieh, I Chang ^a   Chen, Yeung Jen ^a   Kuo, Li Tang ^a   Yang, Ning I ^a   Wang, Shin Yi ^a   Wu, Mei Yun ^a   Hsu, Chia Ming ^a   Cheng, Chi Wen ^a   Cherng, Wen Jin ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Angiotensin converting enzyme; CD26 dipeptidylpeptidase IV; Enalapril; Endothelial progenitor cell; Ischemia

Indexed keywords

CD31 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; DIPROTIN A; ENALAPRIL; PHOSPHODIESTERASE IV INHIBITOR; PROTEIN; STEM CELL FACTOR; STROMA DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD LEVEL; BONE MARROW; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; LIMB ISCHEMIA; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; STEM CELL MOBILIZATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIGENS, CD26; BLOOD; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINES, CXC; CYTOKINES; ENALAPRIL; EPITHELIAL CELLS; HUMANS; ISCHEMIA; LOWER EXTREMITY; MALE; MICE; MICE, INBRED C57BL; OLIGOPEPTIDES; STEM CELLS;

EID: 33745424146     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.03.006     Document Type: Article

References (32)

1. Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024
2. Griese D.P., Ehsan A., Melo L.G., Kong D., Zhang L., Mann M.J., et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108 (2003) 2710-2715
3. Bhattacharya V., McSweeney P.A., Shi Q., Bruno B., Ishida A., Nash R., et al. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood 95 (2000) 581-585
4. Kaushal S., Amiel G.E., Guleserian K.J., Shapira O.M., Perry T., Sutherland F.W., et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat. Med. 7 (2001) 1035-1040
5. Zhang Z.G., Zhang L., Jiang Q., and Chopp M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ. Res. 90 (2002) 284-288
6. Heeschen C., Lehmann R., Honold J., Assmus B., Aicher A., Walter D.H., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109 (2004) 1615-1622
7. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7 (2001) 430-436
8. Herrera C., Morimoto C., Blanco J., Mallol J., Arenzana F., Lluis C., et al. Comodulation of CXCR4 and CD26 in human lymphocytes. J. Biol. Chem. 276 (2001) 19532-19539
9. Christopherson K.W., Hangoc G., Mantel C.R., and Broxmeyer H.E. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305 (2004) 1000-1003
10. Lefebvre J., Murphey L.J., Hartert T.V., Jiao S.R., Simmons W.H., and Brown N.J. Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema. Hypertension 39 (2002) 460-464
11. Hsiao Y.C., Chang H.H., Tsai C.Y., Jong Y.J., Horng L.S., Lin S.F., et al. Coat color-tagged green mouse with EGFP expressed from the RNA polymerase II promoter. Genesis 39 (2004) 122-129
12. Verma S., Wang C.H., Li S.H., Dumont A.S., Fedak P.W., Badiwala M.V., et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106 (2002) 913-919
13. Verma S., Kuliszewski M.A., Li S.H., Szmitko P.E., Zucco L., Wang C.H., et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109 (2004) 2058-2067
14. Nagatsu T., Hino M., Fuyamada H., Hayakawa T., and Sakakibara S. New chromogenic substrates for X-prolyl dipeptidyl-aminopeptidase. Anal. Biochem. 74 (1976) 466-476
15. Jackson K.A., Majka S.M., Wang H., Pocius J., Hartley C.J., Majesky M.W., et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107 (2001) 1395-1402
16. Hiasa K., Ishibashi M., Ohtani K., Inoue S., Zhao Q., Kitamoto S., et al. Gene transfer of stromal cell-derived factor-1{alpha} enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 109 (2004) 2454-2461
17. Wang C.H., Ciliberti N., Li S.H., Szmitko P.E., Weisel R.D., Fedak P.W.M., et al. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation 109 (2004) 1392-1400
18. Flather M.D., Yusuf S., Kober L., Pfeffer M., Hall A., Murray G., et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 355 (2000) 1575-1581
19. Latini R., Tognoni G., Maggioni A.P., Baigent C., Braunwald E., Chen Z.M., et al. Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group. J. Am. Coll. Cardiol. 35 (2000) 1801-1807
20. Christopherson K.W., Hangoc G., and Broxmeyer H.E. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J. Immunol. 169 (2002) 7000-7008
21. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107 (2003) 1322-1328
22. Fabre J.E., Rivard A., Magner M., Silver M., and Isner J.M. Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. Circulation 99 (1999) 3043-3049
23. Michel F., Ambroisine M.L., Duriez M., Delcayre C., Levy B.I., and Silvestre J.S. Aldosterone enhances ischemia-induced neovascularization through angiotensin II-dependent pathway. Circulation 109 (2004) 1933-1937
24. Unger T., Mattfeldt T., Lamberty V., Bock P., Mall G., Linz W., et al. Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension 20 (1992) 478-482
25. Walther T., Menrad A., Orzechowski H.D., Siemeister G., Paul M., and Schirner M. Differential regulation of in vivo angiogenesis by angiotensin II receptors. FASEB J. 17 (2003) 2061-2067
26. Min T.Q., Zhu C.J., Xiang W.X., Hui Z.J., and Peng S.Y. Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc. Drugs Ther. 18 (2004) 203-209
27. Korom S., De M., De I., Korom S., Stadlbauer T.H., Chandraker A., Schaub M., Sayegh M.H., et al. Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. Transplantation 63 (1997) 1495-1500
28. Waltman T.J., Harris T.J., Cesario D., Ziegler M., and Maisel A.S. Effects of enalapril on T and B cell function in rats after myocardial infarction. J. Card. Fail. 1 (1995) 293-302
29. Ikushima H., Munakata Y., Ishii T., Iwata S., Terashima M., Tanaka H., et al. Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8439-8444
30. Saris J.J., Derkx F.H., Lamers J.M., Saxena P.R., Schalekamp M.A., and Danser A.H. Cardiomyocytes bind and activate native human prorenin: role of soluble mannose 6-phosphate receptors. Hypertension 37 (2001) 710-715
31. Christopherson K.W., Cooper S., Hangoc G., and Broxmeyer H.E. CD26 is essential for normal G-CSF-induced progenitor cell mobilization as determined by CD26-/- mice. Exp. Hematol. 31 (2003) 1126-1134
32. Christopherson K.W., Cooper S., and Broxmeyer H.E. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood 101 (2003) 4680-4686